AU6174600A - Screen for nitric oxide synthase modulators - Google Patents

Screen for nitric oxide synthase modulators

Info

Publication number
AU6174600A
AU6174600A AU61746/00A AU6174600A AU6174600A AU 6174600 A AU6174600 A AU 6174600A AU 61746/00 A AU61746/00 A AU 61746/00A AU 6174600 A AU6174600 A AU 6174600A AU 6174600 A AU6174600 A AU 6174600A
Authority
AU
Australia
Prior art keywords
screen
nitric oxide
oxide synthase
synthase modulators
modulators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61746/00A
Inventor
Ian George Charles
Lizhi Liu
Weiming Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9918075.4A external-priority patent/GB9918075D0/en
Priority claimed from GB0016174A external-priority patent/GB0016174D0/en
Application filed by University College London filed Critical University College London
Publication of AU6174600A publication Critical patent/AU6174600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU61746/00A 1999-07-30 2000-07-28 Screen for nitric oxide synthase modulators Abandoned AU6174600A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9918075.4A GB9918075D0 (en) 1999-07-30 1999-07-30 Screen for nitric oxide synthase modulators
GB9918075 1999-07-30
GB0016174 2000-06-30
GB0016174A GB0016174D0 (en) 2000-06-30 2000-06-30 Screen for nitric acid synthase modulators
PCT/GB2000/002926 WO2001009307A2 (en) 1999-07-30 2000-07-28 Screen for nitric oxide synthase modulators

Publications (1)

Publication Number Publication Date
AU6174600A true AU6174600A (en) 2001-02-19

Family

ID=26244582

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61746/00A Abandoned AU6174600A (en) 1999-07-30 2000-07-28 Screen for nitric oxide synthase modulators

Country Status (3)

Country Link
EP (1) EP1203095A2 (en)
AU (1) AU6174600A (en)
WO (1) WO2001009307A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759836A (en) * 1995-03-27 1998-06-02 Hospital For Joint Diseases Osteoarthritis-associated inducable isoform of nitric oxide synthetase
US6150500A (en) * 1996-07-12 2000-11-21 Salerno; John C. Activators of endothelial nitric oxide synthase
CA2274102A1 (en) * 1996-12-09 1998-06-18 Ariad Gene Therapeutics, Inc. Expression of proteins for treating asthma via ligand mediated activation of their encoding genes
HN1998000125A (en) * 1997-08-28 1999-02-09 Pfizer Prod Inc 2-AMINOPYRIDIDS WITH BRANCHED ALCOXY SUBSTITUTES

Also Published As

Publication number Publication date
EP1203095A2 (en) 2002-05-08
WO2001009307A2 (en) 2001-02-08
WO2001009307A3 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
AU4038800A (en) Nutraceuticals having
AU2001252612A1 (en) Ppargamma modulators
AU4211000A (en) Extremely high resolution foveated display
AU3240500A (en) Display device
AU4939400A (en) Meter
AU4340900A (en) Devices
AU1247201A (en) Screen system
EP1065552A3 (en) Projection display devices
AU2453800A (en) Display device
AU7684500A (en) Lpl potentiators
AU6062700A (en) Devices
AU1879701A (en) Display device
AU1533601A (en) Hollow-needle devices
AU6228899A (en) Spacer
AU3775100A (en) Banners
AU1314801A (en) Non-incendiary displays
AU6174600A (en) Screen for nitric oxide synthase modulators
AU6062600A (en) Devices
AU6857600A (en) Screen
GB9918075D0 (en) Screen for nitric oxide synthase modulators
AU3812499A (en) Stopper
AU7421200A (en) Device
AU2313000A (en) Display device
AU2002211068A1 (en) Nuclear transmutational processes
AU3337600A (en) Alignment device

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase